rs6066029
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_022829.6(SLC13A3):c.1016+271G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.127 in 152,160 control chromosomes in the GnomAD database, including 1,460 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_022829.6 intron
Scores
Clinical Significance
Conservation
Publications
- leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarateInheritance: AR, Unknown Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, Illumina
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_022829.6. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC13A3 | TSL:1 MANE Select | c.1016+271G>A | intron | N/A | ENSP00000279027.4 | Q8WWT9-1 | |||
| SLC13A3 | TSL:1 | c.875+271G>A | intron | N/A | ENSP00000419621.1 | Q8WWT9-6 | |||
| SLC13A3 | TSL:5 | c.875+271G>A | intron | N/A | ENSP00000290317.5 | Q8WWT9-6 |
Frequencies
GnomAD3 genomes AF: 0.126 AC: 19231AN: 152042Hom.: 1453 Cov.: 32 show subpopulations
GnomAD4 genome AF: 0.127 AC: 19257AN: 152160Hom.: 1460 Cov.: 32 AF XY: 0.130 AC XY: 9692AN XY: 74394 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at